nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—PTGS2—pancreatitis	0.819	1	CbGaD
Triamcinolone—Dermatitis atopic—Propantheline—pancreatitis	0.0103	0.0757	CcSEcCtD
Triamcinolone—Intraocular pressure increased—Hyoscyamine—pancreatitis	0.00889	0.0652	CcSEcCtD
Triamcinolone—Blindness—Hyoscyamine—pancreatitis	0.00706	0.0518	CcSEcCtD
Triamcinolone—Stinging—Hyoscyamine—pancreatitis	0.00483	0.0354	CcSEcCtD
Triamcinolone—Abdominal distension—Propantheline—pancreatitis	0.00482	0.0354	CcSEcCtD
Triamcinolone—Petechiae—Hyoscyamine—pancreatitis	0.00475	0.0349	CcSEcCtD
Triamcinolone—Fluocinonide—SMO—pancreatitis	0.00427	0.491	CrCbGaD
Triamcinolone—Dermatitis contact—Hyoscyamine—pancreatitis	0.00386	0.0283	CcSEcCtD
Triamcinolone—Skin exfoliation—Hyoscyamine—pancreatitis	0.00373	0.0274	CcSEcCtD
Triamcinolone—Pulmonary oedema—Hyoscyamine—pancreatitis	0.00348	0.0255	CcSEcCtD
Triamcinolone—Osteoarthritis—Hyoscyamine—pancreatitis	0.00284	0.0208	CcSEcCtD
Triamcinolone—Dry mouth—Propantheline—pancreatitis	0.00278	0.0204	CcSEcCtD
Triamcinolone—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—pancreatitis	0.00278	0.077	CbGpPWpGaD
Triamcinolone—Anaphylactic shock—Propantheline—pancreatitis	0.00273	0.02	CcSEcCtD
Triamcinolone—Cardiac arrest—Hyoscyamine—pancreatitis	0.0027	0.0198	CcSEcCtD
Triamcinolone—Tachycardia—Propantheline—pancreatitis	0.00266	0.0195	CcSEcCtD
Triamcinolone—Abdominal distension—Hyoscyamine—pancreatitis	0.00247	0.0181	CcSEcCtD
Triamcinolone—Insomnia—Propantheline—pancreatitis	0.00246	0.0181	CcSEcCtD
Triamcinolone—Betamethasone—PLA2G1B—pancreatitis	0.00232	0.266	CrCbGaD
Triamcinolone—Feeling abnormal—Propantheline—pancreatitis	0.00225	0.0165	CcSEcCtD
Triamcinolone—Urticaria—Propantheline—pancreatitis	0.00216	0.0159	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Hyoscyamine—pancreatitis	0.00216	0.0158	CcSEcCtD
Triamcinolone—Myocardial infarction—Hyoscyamine—pancreatitis	0.00214	0.0157	CcSEcCtD
Triamcinolone—Conjunctivitis—Hyoscyamine—pancreatitis	0.00213	0.0156	CcSEcCtD
Triamcinolone—Hypersensitivity—Propantheline—pancreatitis	0.00201	0.0147	CcSEcCtD
Triamcinolone—Bradycardia—Hyoscyamine—pancreatitis	0.002	0.0147	CcSEcCtD
Triamcinolone—Asthenia—Propantheline—pancreatitis	0.00196	0.0143	CcSEcCtD
Triamcinolone—Dizziness—Propantheline—pancreatitis	0.0018	0.0132	CcSEcCtD
Triamcinolone—Arrhythmia—Hyoscyamine—pancreatitis	0.00175	0.0129	CcSEcCtD
Triamcinolone—Vomiting—Propantheline—pancreatitis	0.00173	0.0127	CcSEcCtD
Triamcinolone—Rash—Propantheline—pancreatitis	0.00172	0.0126	CcSEcCtD
Triamcinolone—Dermatitis—Propantheline—pancreatitis	0.00172	0.0126	CcSEcCtD
Triamcinolone—Erythema—Hyoscyamine—pancreatitis	0.00171	0.0125	CcSEcCtD
Triamcinolone—Headache—Propantheline—pancreatitis	0.00171	0.0125	CcSEcCtD
Triamcinolone—Dysgeusia—Hyoscyamine—pancreatitis	0.00167	0.0123	CcSEcCtD
Triamcinolone—Nausea—Propantheline—pancreatitis	0.00162	0.0119	CcSEcCtD
Triamcinolone—Angioedema—Hyoscyamine—pancreatitis	0.00156	0.0115	CcSEcCtD
Triamcinolone—Vertigo—Hyoscyamine—pancreatitis	0.00154	0.0113	CcSEcCtD
Triamcinolone—Syncope—Hyoscyamine—pancreatitis	0.00153	0.0112	CcSEcCtD
Triamcinolone—Loss of consciousness—Hyoscyamine—pancreatitis	0.0015	0.011	CcSEcCtD
Triamcinolone—Convulsion—Hyoscyamine—pancreatitis	0.00148	0.0109	CcSEcCtD
Triamcinolone—Dry mouth—Hyoscyamine—pancreatitis	0.00142	0.0104	CcSEcCtD
Triamcinolone—Anaphylactic shock—Hyoscyamine—pancreatitis	0.0014	0.0102	CcSEcCtD
Triamcinolone—Oedema—Hyoscyamine—pancreatitis	0.0014	0.0102	CcSEcCtD
Triamcinolone—Shock—Hyoscyamine—pancreatitis	0.00137	0.0101	CcSEcCtD
Triamcinolone—Tachycardia—Hyoscyamine—pancreatitis	0.00136	0.00999	CcSEcCtD
Triamcinolone—Dexamethasone—PLA2G1B—pancreatitis	0.00135	0.155	CrCbGaD
Triamcinolone—Hyperhidrosis—Hyoscyamine—pancreatitis	0.00135	0.00989	CcSEcCtD
Triamcinolone—Insomnia—Hyoscyamine—pancreatitis	0.00126	0.00926	CcSEcCtD
Triamcinolone—Dyspnoea—Hyoscyamine—pancreatitis	0.00124	0.00912	CcSEcCtD
Triamcinolone—Dyspepsia—Hyoscyamine—pancreatitis	0.00123	0.00901	CcSEcCtD
Triamcinolone—Fatigue—Hyoscyamine—pancreatitis	0.0012	0.00882	CcSEcCtD
Triamcinolone—Pain—Hyoscyamine—pancreatitis	0.00119	0.00875	CcSEcCtD
Triamcinolone—BCHE—Synthesis, secretion, and deacylation of Ghrelin—GCG—pancreatitis	0.00115	0.0319	CbGpPWpGaD
Triamcinolone—Feeling abnormal—Hyoscyamine—pancreatitis	0.00115	0.00843	CcSEcCtD
Triamcinolone—Urticaria—Hyoscyamine—pancreatitis	0.00111	0.00813	CcSEcCtD
Triamcinolone—Body temperature increased—Hyoscyamine—pancreatitis	0.0011	0.00809	CcSEcCtD
Triamcinolone—BCHE—Peptide hormone metabolism—CPB1—pancreatitis	0.00105	0.0292	CbGpPWpGaD
Triamcinolone—Hypersensitivity—Hyoscyamine—pancreatitis	0.00103	0.00754	CcSEcCtD
Triamcinolone—Asthenia—Hyoscyamine—pancreatitis	0.001	0.00734	CcSEcCtD
Triamcinolone—Pruritus—Hyoscyamine—pancreatitis	0.000987	0.00724	CcSEcCtD
Triamcinolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—pancreatitis	0.000926	0.0257	CbGpPWpGaD
Triamcinolone—Dizziness—Hyoscyamine—pancreatitis	0.000923	0.00677	CcSEcCtD
Triamcinolone—CYP3A4—Fatty Acid Omega Oxidation—ADH4—pancreatitis	0.000912	0.0253	CbGpPWpGaD
Triamcinolone—Vomiting—Hyoscyamine—pancreatitis	0.000887	0.00651	CcSEcCtD
Triamcinolone—Rash—Hyoscyamine—pancreatitis	0.00088	0.00645	CcSEcCtD
Triamcinolone—Dermatitis—Hyoscyamine—pancreatitis	0.000879	0.00645	CcSEcCtD
Triamcinolone—Headache—Hyoscyamine—pancreatitis	0.000874	0.00641	CcSEcCtD
Triamcinolone—Nausea—Hyoscyamine—pancreatitis	0.000829	0.00608	CcSEcCtD
Triamcinolone—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—pancreatitis	0.000757	0.021	CbGpPWpGaD
Triamcinolone—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pancreatitis	0.00068	0.0189	CbGpPWpGaD
Triamcinolone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—CTRB2—pancreatitis	0.000669	0.0186	CbGpPWpGaD
Triamcinolone—BCHE—Synthesis, secretion, and deacylation of Ghrelin—INS—pancreatitis	0.000647	0.0179	CbGpPWpGaD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—LEP—pancreatitis	0.00056	0.0155	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—DUSP1—pancreatitis	0.000552	0.0153	CbGpPWpGaD
Triamcinolone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—PRSS1—pancreatitis	0.000507	0.0141	CbGpPWpGaD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—pancreatitis	0.000487	0.0135	CbGpPWpGaD
Triamcinolone—PTGS2—Overview of nanoparticle effects—CRP—pancreatitis	0.000487	0.0135	CbGpPWpGaD
Triamcinolone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—PRSS3—pancreatitis	0.000481	0.0133	CbGpPWpGaD
Triamcinolone—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—pancreatitis	0.000479	0.0133	CbGpPWpGaD
Triamcinolone—BCHE—Glycerophospholipid biosynthesis—PLA2G1B—pancreatitis	0.000462	0.0128	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—FGG—pancreatitis	0.000461	0.0128	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—XDH—pancreatitis	0.000427	0.0118	CbGpPWpGaD
Triamcinolone—NR3C1—Endoderm Differentiation—PTHLH—pancreatitis	0.000423	0.0117	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of Androgen receptor activity—EGR1—pancreatitis	0.000408	0.0113	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IL13—pancreatitis	0.000379	0.0105	CbGpPWpGaD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.000341	0.00946	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—EGR1—pancreatitis	0.000326	0.00905	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—EGR1—pancreatitis	0.000324	0.00898	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PLA2G1B—pancreatitis	0.000322	0.00893	CbGpPWpGaD
Triamcinolone—BCHE—Peptide hormone metabolism—GCG—pancreatitis	0.000318	0.00881	CbGpPWpGaD
Triamcinolone—PTGS2—Overview of nanoparticle effects—CXCL8—pancreatitis	0.000317	0.00879	CbGpPWpGaD
Triamcinolone—NR3C1—Nuclear Receptors—PPARG—pancreatitis	0.000315	0.00873	CbGpPWpGaD
Triamcinolone—Betamethasone—PTGS2—pancreatitis	0.000297	0.0342	CrCbGaD
Triamcinolone—Prednisone—ALB—pancreatitis	0.000293	0.0337	CrCbGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—EGR1—pancreatitis	0.000288	0.00798	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP12—pancreatitis	0.000287	0.00797	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—MPO—pancreatitis	0.000282	0.00782	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—LPL—pancreatitis	0.00028	0.00778	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.000276	0.00767	CbGpPWpGaD
Triamcinolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—pancreatitis	0.000275	0.00762	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—MPO—pancreatitis	0.000272	0.00754	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—IL10—pancreatitis	0.000269	0.00747	CbGpPWpGaD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—pancreatitis	0.000259	0.00718	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—PPP3CA—pancreatitis	0.000258	0.00716	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.000257	0.00713	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—TACR1—pancreatitis	0.000256	0.0071	CbGpPWpGaD
Triamcinolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—pancreatitis	0.000252	0.00698	CbGpPWpGaD
Triamcinolone—NR3C1—Nuclear Receptor transcription pathway—PPARG—pancreatitis	0.000249	0.0069	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TACR1—pancreatitis	0.000243	0.00673	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—pancreatitis	0.00024	0.00665	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL13—pancreatitis	0.000227	0.00629	CbGpPWpGaD
Triamcinolone—PTGS2—Overview of nanoparticle effects—TNF—pancreatitis	0.000221	0.00612	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—ALDH2—pancreatitis	0.000211	0.00586	CbGpPWpGaD
Triamcinolone—BCHE—Peptide hormone metabolism—LEP—pancreatitis	0.000209	0.0058	CbGpPWpGaD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—pancreatitis	0.000209	0.00579	CbGpPWpGaD
Triamcinolone—CYP3A4—Tryptophan metabolism—ALDH2—pancreatitis	0.000206	0.00571	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—SST—pancreatitis	0.000199	0.00552	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CPB1—pancreatitis	0.000199	0.00551	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of Androgen receptor activity—MDM2—pancreatitis	0.000197	0.00546	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—PPP3CA—pancreatitis	0.000197	0.00546	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.000192	0.00531	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—pancreatitis	0.000192	0.00531	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—FDX1—pancreatitis	0.000188	0.0052	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—CCL2—pancreatitis	0.000186	0.00517	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—pancreatitis	0.000183	0.00509	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—HSP90AB1—pancreatitis	0.000181	0.00503	CbGpPWpGaD
Triamcinolone—BCHE—Peptide hormone metabolism—INS—pancreatitis	0.000179	0.00495	CbGpPWpGaD
Triamcinolone—PTGS2—Overview of nanoparticle effects—IL6—pancreatitis	0.000178	0.00494	CbGpPWpGaD
Triamcinolone—Dexamethasone—PTGS2—pancreatitis	0.000173	0.0199	CrCbGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—EGR1—pancreatitis	0.000172	0.00477	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—KLK1—pancreatitis	0.000169	0.00469	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—EGR1—pancreatitis	0.000163	0.00452	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—ALDH2—pancreatitis	0.000162	0.00449	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—LPL—pancreatitis	0.000161	0.00447	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PNLIP—pancreatitis	0.000155	0.00431	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—CXCL8—pancreatitis	0.000147	0.00409	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—FDX1—pancreatitis	0.000147	0.00407	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—pancreatitis	0.000146	0.00405	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—CRP—pancreatitis	0.000143	0.00396	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL10—pancreatitis	0.000142	0.00394	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—pancreatitis	0.00014	0.00389	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—pancreatitis	0.00014	0.00388	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—pancreatitis	0.000139	0.00385	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—ADH4—pancreatitis	0.000136	0.00379	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—LEP—pancreatitis	0.000135	0.00375	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.000135	0.00374	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—ICAM1—pancreatitis	0.000131	0.00364	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—pancreatitis	0.00013	0.0036	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—FDX1—pancreatitis	0.000129	0.00358	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—HTR2A—pancreatitis	0.000126	0.00348	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—NRAS—pancreatitis	0.000125	0.00348	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—INS—pancreatitis	0.00012	0.00331	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—PPARG—pancreatitis	0.000118	0.00326	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—CCL2—pancreatitis	0.000118	0.00326	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—INS—pancreatitis	0.000115	0.0032	CbGpPWpGaD
Triamcinolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	0.000114	0.00316	CbGpPWpGaD
Triamcinolone—NR3C1—Endoderm Differentiation—TGFB1—pancreatitis	0.000112	0.00312	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—EGR1—pancreatitis	0.000111	0.00307	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—LEP—pancreatitis	0.000111	0.00307	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—TGFB1—pancreatitis	0.00011	0.00305	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—ALB—pancreatitis	0.00011	0.00304	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—TNF—pancreatitis	0.000109	0.00302	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TLR4—pancreatitis	0.000108	0.00301	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—pancreatitis	0.000108	0.00299	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PNLIP—pancreatitis	0.000107	0.00297	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—ICAM1—pancreatitis	0.000104	0.00288	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	0.000104	0.00288	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—ADH1B—pancreatitis	0.000102	0.00282	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—pancreatitis	0.000102	0.00282	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFA—pancreatitis	0.000101	0.0028	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—A2M—pancreatitis	0.0001	0.00278	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CTRB2—pancreatitis	9.63e-05	0.00267	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CCL2—pancreatitis	9.3e-05	0.00258	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—pancreatitis	9.17e-05	0.00254	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL1B—pancreatitis	8.92e-05	0.00247	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—FDX1—pancreatitis	8.35e-05	0.00232	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—IL6—pancreatitis	8.27e-05	0.0023	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CTRB2—pancreatitis	7.92e-05	0.0022	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ADH4—pancreatitis	7.76e-05	0.00215	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—pancreatitis	7.76e-05	0.00215	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—NRAS—pancreatitis	7.74e-05	0.00215	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—MDM2—pancreatitis	7.49e-05	0.00208	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL1B—pancreatitis	7.44e-05	0.00206	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—CASP3—pancreatitis	7.43e-05	0.00206	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CXCL8—pancreatitis	7.35e-05	0.00204	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PRSS1—pancreatitis	7.3e-05	0.00202	CbGpPWpGaD
Triamcinolone—CYP3A4—Tryptophan metabolism—MDM2—pancreatitis	7.3e-05	0.00202	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—pancreatitis	7.29e-05	0.00202	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—ALDH2—pancreatitis	7.17e-05	0.00199	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	7.14e-05	0.00198	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL1B—pancreatitis	7.05e-05	0.00196	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CASP3—pancreatitis	7.04e-05	0.00195	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PRSS3—pancreatitis	6.92e-05	0.00192	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PNLIP—pancreatitis	6.92e-05	0.00192	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—A2M—pancreatitis	6.89e-05	0.00191	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TGFB1—pancreatitis	6.69e-05	0.00186	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—KRAS—pancreatitis	6.66e-05	0.00185	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CTRB2—pancreatitis	6.63e-05	0.00184	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—TNF—pancreatitis	6.47e-05	0.00179	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TNF—pancreatitis	6.25e-05	0.00173	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—XDH—pancreatitis	6.21e-05	0.00172	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PRSS1—pancreatitis	6e-05	0.00166	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—GCG—pancreatitis	6e-05	0.00166	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ADH1B—pancreatitis	5.79e-05	0.00161	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—FDX1—pancreatitis	5.75e-05	0.00159	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—MDM2—pancreatitis	5.74e-05	0.00159	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PNLIP—pancreatitis	5.69e-05	0.00158	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PRSS3—pancreatitis	5.69e-05	0.00158	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—HRAS—pancreatitis	5.66e-05	0.00157	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TGFB1—pancreatitis	5.48e-05	0.00152	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—LPL—pancreatitis	5.45e-05	0.00151	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—TNF—pancreatitis	5.4e-05	0.0015	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—pancreatitis	5.35e-05	0.00148	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ADH4—pancreatitis	5.34e-05	0.00148	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL6—pancreatitis	5.22e-05	0.00145	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TNF—pancreatitis	5.12e-05	0.00142	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—LTF—pancreatitis	5.1e-05	0.00142	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IL6—pancreatitis	5.04e-05	0.0014	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PRSS1—pancreatitis	5.02e-05	0.00139	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	4.79e-05	0.00133	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PRSS3—pancreatitis	4.76e-05	0.00132	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PNLIP—pancreatitis	4.76e-05	0.00132	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PLA2G1B—pancreatitis	4.62e-05	0.00128	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—A2M—pancreatitis	4.46e-05	0.00124	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL6—pancreatitis	4.36e-05	0.00121	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—PPARG—pancreatitis	4.3e-05	0.00119	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—XDH—pancreatitis	4.27e-05	0.00119	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL6—pancreatitis	4.13e-05	0.00115	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—HRAS—pancreatitis	4.11e-05	0.00114	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALDH2—pancreatitis	4.08e-05	0.00113	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ADH1B—pancreatitis	3.98e-05	0.00111	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	3.98e-05	0.0011	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—LEP—pancreatitis	3.94e-05	0.00109	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—LPL—pancreatitis	3.75e-05	0.00104	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	3.73e-05	0.00103	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—ALB—pancreatitis	3.58e-05	0.000992	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	3.48e-05	0.000966	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	3.45e-05	0.000958	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—INS—pancreatitis	3.37e-05	0.000935	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FGA—pancreatitis	3.35e-05	0.00093	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CCL2—pancreatitis	3.32e-05	0.00092	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PLA2G1B—pancreatitis	3.18e-05	0.000882	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—HRAS—pancreatitis	3.15e-05	0.000873	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	3.13e-05	0.000868	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GCG—pancreatitis	3.09e-05	0.000857	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—A2M—pancreatitis	3.07e-05	0.000851	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PPP3CA—pancreatitis	2.97e-05	0.000825	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CTRB2—pancreatitis	2.9e-05	0.000803	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALDH2—pancreatitis	2.81e-05	0.000779	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	2.74e-05	0.000759	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CXCL8—pancreatitis	2.62e-05	0.000727	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—FDX1—pancreatitis	2.51e-05	0.000696	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	2.46e-05	0.000683	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—LPL—pancreatitis	2.43e-05	0.000673	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ADH4—pancreatitis	2.33e-05	0.000647	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PDGFA—pancreatitis	2.24e-05	0.000622	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PRSS1—pancreatitis	2.19e-05	0.000609	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GCG—pancreatitis	2.13e-05	0.00059	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PNLIP—pancreatitis	2.08e-05	0.000577	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PRSS3—pancreatitis	2.08e-05	0.000577	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PPARG—pancreatitis	2.07e-05	0.000574	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—LPL—pancreatitis	1.99e-05	0.000553	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—XDH—pancreatitis	1.87e-05	0.000518	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PPARG—pancreatitis	1.77e-05	0.000491	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ADH1B—pancreatitis	1.74e-05	0.000483	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—INS—pancreatitis	1.74e-05	0.000482	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—LPL—pancreatitis	1.67e-05	0.000463	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALB—pancreatitis	1.59e-05	0.000442	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—INS—pancreatitis	1.43e-05	0.000396	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTGS2—pancreatitis	1.39e-05	0.000386	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PLA2G1B—pancreatitis	1.39e-05	0.000385	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—A2M—pancreatitis	1.34e-05	0.000372	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALDH2—pancreatitis	1.23e-05	0.00034	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PPARG—pancreatitis	1.22e-05	0.000338	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—INS—pancreatitis	1.2e-05	0.000332	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MDM2—pancreatitis	1.19e-05	0.000329	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALB—pancreatitis	1.1e-05	0.000304	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GCG—pancreatitis	9.29e-06	0.000258	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NRAS—pancreatitis	8.91e-06	0.000247	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TGFB1—pancreatitis	8.28e-06	0.00023	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—KRAS—pancreatitis	7.67e-06	0.000213	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LPL—pancreatitis	7.29e-06	0.000202	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HRAS—pancreatitis	6.52e-06	0.000181	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IL6—pancreatitis	6.24e-06	0.000173	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PPARG—pancreatitis	5.32e-06	0.000148	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—INS—pancreatitis	5.22e-06	0.000145	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALB—pancreatitis	4.79e-06	0.000133	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTGS2—pancreatitis	4.19e-06	0.000116	CbGpPWpGaD
